title: Purinergic signaling involved in Müller cell function in the mammalian retina.
abstract: Purines (in particular, ATP and adenosine) act as neuro- and gliotransmitters in the sensory retina where they are involved in bidirectional neuron-glia signaling. This review summarizes the present knowledge about the expression and functional importance of P1 (adenosine) and P2 (nucleotide) receptors in Müller glial cells of the mammalian retina. Mammalian Müller cells express various subtypes of adenosine receptors and metabotropic P2Y receptors. Human Müller cells also express ionotropic P2X(7) receptors. Müller cells release ATP upon activation of metabotropic glutamate receptors and/or osmotic membrane stretching. The osmotic mechanism is abrogated under conditions associated with ischemia-hypoxia and inflammation, resulting in swelling of the Müller cells when the extracellular milieu is hypoosmotic. However, exogenous glutamate, which induces the release of ATP and adenosine, and thus activates P2Y(1) and A(1) adenosine receptors, respectively, prevents such osmotic swelling under pathological conditions, suggesting unimpaired receptor-induced release of ATP. In addition to the inhibition of swelling, which is implicated in regulating the volume of the extracellular space, purinergic signaling is involved in mediating neurovascular coupling. Furthermore, purinergic signals stimulate the proliferation of retinal precursor cells and Müller cells. In normal retinal information processing, Müller cells regulate the synaptic activity by the release of ATP and adenosine. In retinopathies, abrogation of the osmotic release of ATP, and the upregulation of ecto-apyrase (NTPDase1), may have neuroprotective effects by preventing the overactivation of neuronal P2X receptors that are implicated in apoptotic cell death. Pharmacological modulation of purinergic receptors of Müller cells may have clinical importance, e.g., for the clearance of retinal edema and for the inhibition of dysregulated cell proliferation in proliferative retinopathies.
authors.affiliation: Paul Flechsig Institute of Brain Research, University of Leipzig, 04109 Leipzig, Germany.
authors.forename: Antje
authors.initials: A
authors.lastname: Wurm
authors.forename: Thomas
authors.initials: T
authors.lastname: Pannicke
authors.forename: Ianors
authors.initials: I
authors.lastname: Iandiev
authors.forename: Mike
authors.initials: M
authors.lastname: Francke
authors.forename: Margrit
authors.initials: M
authors.lastname: Hollborn
authors.forename: Peter
authors.initials: P
authors.lastname: Wiedemann
authors.forename: Andreas
authors.initials: A
authors.lastname: Reichenbach
authors.forename: Neville N
authors.initials: NN
authors.lastname: Osborne
authors.forename: Andreas
authors.initials: A
authors.lastname: Bringmann
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D002118:Calcium / Q000378:metabolism; D006801:Humans; D008322:Mammals / Q000033:anatomy & histology; D008954:Models, Biological; D009457:Neuroglia / Q000378:metabolism*; D011983:Receptors, Purinergic / Q000145:classification / Q000378:metabolism*; D012160:Retina / Q000166:cytology*; D015398:Signal Transduction / Q000502:physiology*
chemical_list: D011983:Receptors, Purinergic; D000255:Adenosine Triphosphate; D002118:Calcium